AN 795 (Imatinib Mesylate 400 mg)
Pill with imprint AN 795 is Brown, Elliptical/Oval and has been identified as Imatinib Mesylate 400 mg. It is supplied by Amneal Pharmaceuticals LLC.
Imatinib is used in the treatment of chronic myelogenous leukemia; dermatofibrosarcoma protuberans; acute lymphoblastic leukemia; chronic eosinophilic leukemia; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for AN 795
Imatinib Mesylate
- Imprint
- AN 795
- Strength
- 400 mg
- Color
- Brown
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals LLC
- National Drug Code (NDC)
- 65162-0795
Related images for "AN 795"
More about imatinib
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (40)
- Drug images
- Pricing & coupons
- En español
- Drug class: BCR-ABL tyrosine kinase inhibitors
Patient resources
- Other brands
- Gleevec
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.